Clinical Trial Update: Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Antithrombin-III for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Veno-occlusive Disease

Drugs mentioned

• Antithrombin III (antithrombin III)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hepatic Veno-Occlusive Disease | Phase 2 | Status: UNKNOWN